cancer and tumor News

Family Tree Dental Group Examines the Risks and Benefits of Dental X-Rays

The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director.

Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation.

Steven Olson of the University of Illinois at Chicago College of Dentistry has received a $3.12 million federal grant for research on anticoagulant proteins that regulate blood clotting and prevent abnormal clotting.

Family Tree Dental Group Examines the Risks and Benefits of Dental X-Rays

Charity Outing Will Support Foundation’s Leading Edge Brain Cancer Research & Clinical Trials in the Greater New York Metropolitan Area - One Lucky Golfer Who Hits a Hole-in-One Will Win a New Porsche 911 Carrera, Courtesy of Pepe Porsche

The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director.

The Caring for Carcinoid Foundation (CFCF) is pleased to announce its celebratory programming in honor of Worldwide NET Cancer Awareness Day. CFCF-sponsored events include a Patient Education Seminar and awarding grants to patient support groups.

Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation.

Steven Olson of the University of Illinois at Chicago College of Dentistry has received a $3.12 million federal grant for research on anticoagulant proteins that regulate blood clotting and prevent abnormal clotting.

New Medical Devices research report from GlobalData is now available from Fast Market Research

Surgeon to Remove Potentially Deadly Tumor near Brainstem

Many new cancer weapons come as personalized therapies that can target specific changes in an individual’s tumor. Leading the work are Binghamton University researchers who are using a new tool in studying tubulin tyrosine ligase, or TTL enzyme.

Immunolizer® is a natural formula scientifically designed to optimize the immune system's performance. Immunolizer® activates the body's defense mechanisms and helps the Immune System to distinguish adequately between self and non-self.

As the Guinness Record holder for operating a 66kg tumor, Dr Makeshwari takes his inspiration from Apple CEO Steve Jobs quote "Innovation distinguishes between a leader and follower."

The study revealed that when the loss of heterozygosity (LOH) was identical (concordant) in the tumors they were metastatic. New multifocal primary cancers had discordant LOH, meaning their LOH was not identical.

Several milestones achieved following its first year treating patients in Suffolk County, New York.

Avastin (bevacizumab; Genentech/Roche/Chugai) is a humanized monoclonal antibody directed towards vascular endothelial growth factor (VEGF). VEGF plays an important role in angiogenesis, a key driver of tumor growth.

Visualase Inc. Selected to Present at Epilepsy Conference Highlighting New and Promising Epilepsy Therapies. Epilepsy Pipeline Update 2010 to Take Place February 25-26 in San Francisco.

The new Business Insights report Cancer Market Outlook to 2014: Competitive landscape, market size, pipeline analysis and growth opportunities looks into what the future holds for players in the fastest growing pharmaceutical market.

Visualase Inc. was selected for a $2.1 million grant from the Cancer Prevention and Research Institute of Texas. The precision and control of the Visualase technology has made possible the ablation of tissue in areas such as brain and prostate.

Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body

Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body.

A study to develop a new genetically engineered vaccine opened officially Oct 16. The program has begun screening patients. Initial clinical trial reported rapid shrinkage and/or disappearance of widespread tumors within eight weeks.

Blogging in B Minor (markmillermusic.org/blog) chronicles Mark Miller's journey as a grade 4 brain tumor survivor and provides other brain tumor survivors with in-depth research information and personal experience to provide hope and encouragement.

Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008.